• ADC Therapeutics granted a new employee options to purchase 17,000 common shares on November 2, 2026, under its Inducement Plan.
• The options vest 25% on the grant's first anniversary, then 1/48th monthly through the fourth anniversary, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADC Therapeutics SA published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611021605PR_NEWS_USPR_____NY85693) on November 02, 2026, and is solely responsible for the information contained therein.